Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 21 - 30 of about 175   

Articles published

GSK 1,425.00 +6.00 (0.42%)
price chart
GlaxoSmithKline plc Given �Hold� Rating at Berenberg Bank (GSK)
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK)'s stock had its �hold� rating reiterated by Berenberg Bank in a research note issued on Tuesday.
Zacks Reiterates �Underperform� Rating for GlaxoSmithKline plc (GSK)
GlaxoSmithKline plc (ADR) logo GlaxoSmithKline plc (NYSE:GSK)'s stock had its �underperform� rating reiterated by Zacks in a report released on Friday.
Why GlaxoSmithKline (GSK) Stock Is Higher Today
"We rate GLAXOSMITHKLINE PLC (GSK) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate.
Why The Chinese Corruption Saga Makes GlaxoSmithKline plc A Dicey Pick
Make no mistake: GlaxoSmithKline's ongoing bribery saga in China shows no signs of disappearing any time soon. Allegations initially emerged in June last year that the company was operating a vast slush fund to bribe doctors with cash and other ...
GSK's Mark Reilly In Another Scandal, This Time Over Sex Tape  Bidness Etc
China says GSK-linked trial being handled according to law  Reuters UK
Related articles »  
Drug Maker on Negative Moves- GlaxoSmithKline plc (ADR) (NYSE:GSK ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) [Trend Analysis] hits intraday high level of $48.98, while after all it dropped -2.96% or -$1.48 to close stocks trading at $48.60 in latest trading session.
Related articles »  
GlaxoSmithKline plc Stock Rating Reaffirmed by Credit Suisse (GSK)
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK)'s stock had its �underperform� rating reiterated by equities researchers at Credit Suisse in a research report issued on Friday.
Related articles »  
GlaxoSmithKline plc (NYSE: GSK) Faces Corruption Rumors In Syria
Allegations of corruption against GlaxoSmithKline (NYSE: GSK) are coming out of Syria. The drug making company and its distributer have been accused of bribing authorities to close business, according to an anonymous email detailing the company's ...
Glaxo Investigates Allegations of Bribery in Syria  Businessweek
Related articles »  
GlaxoSmithKline plc (ADR) (GSK) Announces Quarterly Dividend of $0.65
GlaxoSmithKline plc logo GlaxoSmithKline plc (NYSE:GSK) declared a quarterly dividend on Thursday, July 24th, American Banking News.
Why GlaxoSmithKline (GSK) Stock Continues To Sink Today
"We rate GLAXOSMITHKLINE PLC (GSK) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate.
Related articles »  
GlaxoSmithKline plc's Hold Rating Reaffirmed at Jefferies Group (GSK)
GlaxoSmithKline plc (ADR) logo GlaxoSmithKline plc (NYSE:GSK)'s stock had its �hold� rating reaffirmed by analysts at Jefferies Group in a research report issued to clients and investors on Friday.